Social and demographic factors, eating habits, and psychological status in developing irritable bowel syndrome

Gaus O.V.; Livzan M.A.

doi:https://doi.org/10.17116/profmed20222511184

Close metadata

OBJECTIVE

To evaluate social and demographic factors, eating habits, and psychological status in developing irritable bowel syndrome (IBS).

MATERIAL AND METHODS

In an open cross-sectional study including 263 patients, the role of social, demographic, psychological, and diet-related factors in developing irritable bowel syndrome (IBS) was evaluated.

RESULTS

It is shown that social and demographic factors such as cesarean birth, formula feeding at an early age, a history of acute enteric infection, intellectual and creative profession, and various types of social stress — divorce, separation from work — are associated with an increased risk of occurrence and persistence of IBS symptoms. An important role is played by an irregular diet, low dietary fiber intake, excessive intake of salt, sweet, starchy, and spicy foods, and low awareness of rational nutrition. Psychological factors (increased anxiety and depression) worsen the disorder.

CONCLUSION

Modifying these factors is necessary to improve the effectiveness of patient care further.

Keywords:

functional gastrointestinal disorders

irritable bowel syndrome

risk factors

social and demographic factors

diet

anxiety

depression

Authors:

Gaus O.V.

Omsk State Medical University

Livzan M.A.

Omsk State Medical University

ORCID: 0000-0002-6581-7017

Received:

22.07.2022

Accepted:

08.09.2022

Close metadata

References:

Creed F. Review article: the incidence and risk factors for irritable bowel syndrome in population-based studies. Alimentary Pharmacology and Therapeutics. 2019;50:507-516. https://doi.org/10.1111/apt.15396
Drossman DA, Hasler WL. Rome IV — Functional Gastrointestinal Disorders: Disorders of Gut-Brain Interaction. Gastroenterology. 2016;150(6):1257-1261. https://doi.org/10.1053/j.gastro.2016.03.035
Ivashkin VT, Maev IV, Shelygin YuA, Baranskaya EK, Belous SS, Belousova EA, Beniashvili AG, Vasil’ev SV, Veselov AV, Grigor’ev EG, Kostenko NV, Kashnikov VN, Kulikovskij VF, Loranskaya ID, Lyashenko OS, Poluektova EA, Rumyancev VG, Timerbulatov VM, Fomenko OYu, Hubezov DA, Chashkova EYu, Chibisov GI, Shapina MV, Sheptulin AA, Shifrin OS, Alekseeva OP, Alekseenko SA, Baranovskij AYu, Zol’nikova OYu, Korochanskaya NV, Mammaev SN, Hlynov IB, Cukanov VV. Diagnosis and Treatment of Irritable Bowel Syndrome: Clinical Recommendations of the Russian Gastroenterological Association and Association of Coloproctologists of Russia. Rossijskij zhurnal gastroenterologii, gepatologii, koloproktologii. 2021;31(5):74-95. (In Russ.). https://doi.org/10.22416/1382-4376-2021-31-5-74-95
WHO Europe. CINDI Health Monitor: A Study of feasibility of a health behaviour monitoring survey across CINDI countries. Data book [Internet]. 2000. Accessed July 19, 2022. https://www.euro.who.int/__data/assets/pdf_file/0017/240236/e79396.pdf
Organizaciya i metodika provedeniya sociologicheskih issledovanij zdorov’ya sel’skogo naseleniya dlya informacionnogo obespecheniya sistemy social’no-gigienicheskogo monitoring. Metodicheskie rekomendacii. Omsk: FGU CGSEN Omskoj oblasti; 2004. (In Russ.).
Oka P, Parr H, Barberio B, et al. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis [published correction appears in Lancet Gastroenterol Hepatol. 2020 Dec;5(12):e8]. The Lancet Gastroenterology and Hepatology. 2020;5(10):908-917. https://doi.org/10.1016/S2468-1253(20)30217-X
Black CJ, Yiannakou Y, Houghton LA, Ford AC. Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria. Clinical Gastroenterology and Hepatology. 2020;18(2):392-398.e2. https://doi.org/10.1016/j.cgh.2019.05.037
Usai P, Manca R, Lai MA, et al. Prevalence of irritable bowel syndrome in Italian rural and urban areas. European Journal of Internal Medicine. 2010; 21(4):324-326. https://doi.org/10.1016/j.ejim.2010.05.009
Latif A, Aziz Memon F, Asad M. Irritable Bowel Syndrome in a Population of a Developing Country: Prevalence and Association. Cureus. 2020;12(5):e8112. https://doi.org/10.7759/cureus.8112
Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196(4286):129-136. https://doi.org/10.1126/science.847460
Chong PP, Chin VK, Looi CY, et al. The Microbiome and Irritable Bowel Syndrome — A Review on the Pathophysiology, Current Research and Future Therapy. Frontiers in Microbiology. 2019;10:1136. https://doi.org/10.3389/fmicb.2019.01136
Jandhyala SM, Talukdar R, Subramanyam C, et al. Role of the normal gut microbiota. World Journal of Gastroenterology. 2015;21(29):8787-8803. https://doi.org/10.3748/wjg.v21.i29.8787
Kim MY, Choi SW. Dietary modulation of gut microbiota for the relief of irritable bowel syndrome. Nutrition Research and Practice. 2021;15(4):411-430. https://doi.org/10.4162/nrp.2021.15.4.411
Klem F, Wadhwa A, Prokop LJ, et al. Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis. Gastroenterology. 2017;152(5):1042-1054.e1. https://doi.org/10.1053/j.gastro.2016.12.039
Cremon C, Stanghellini V, Pallotti F, et al. Salmonella gastroenteritis during childhood is a risk factor for irritable bowel syndrome in adulthood. Gastroenterology. 2014;147(1):69-77. https://doi.org/10.1053/j.gastro.2014.03.013
Spiller R. Impact of Diet on Symptoms of the Irritable Bowel Syndrome. Nutrients. 2021;13(2):575. https://doi.org/10.3390/nu13020575
Algera J, Colomier E, Simrén M. The Dietary Management of Patients with Irritable Bowel Syndrome: A Narrative Review of the Existing and Emerging Evidence. Nutrients. 2019;11(9):2162. https://doi.org/10.3390/nu11092162
Williams EA, Nai X, Corfe BM. Dietary intakes in people with irritable bowel syndrome. BMC Gastroenterology. 2011;11:9. https://doi.org/10.1186/1471-230X-11-9
Monsbakken KW, Vandvik PO, Farup PG. Perceived food intolerance in subjects with irritable bowel syndrome — etiology, prevalence and consequences. European Journal of Clinical Nutrition. 2006;60(5):667-672. https://doi.org/10.1038/sj.ejcn.1602367
El-Salhy M, Gundersen D. Diet in irritable bowel syndrome. Nutrition Journal. 2015;14:36. https://doi.org/10.1186/s12937-015-0022-3
Melchior C, Fremaux S, Jouët P, et al. Perceived Gastrointestinal Symptoms and Association With Meals in a French Cohort of Patients With Irritable Bowel Syndrome. Journal of Neurogastroenterology and Motility. 2021;27(4): 574-580. https://doi.org/10.5056/jnm20201
Böhn L, Störsrud S, Törnblom H, et al. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. American Journal of Gastroenterology. 2013;108(5):634-641. https://doi.org/10.1038/ajg.2013.105
Hayes P, Corish C, O’Mahony E, Quigley EM. A dietary survey of patients with irritable bowel syndrome. Journal of Human Nutrition and Dietetics. 2014;27(suppl 2):36-47. https://doi.org/10.1111/jhn.12114
McKenzie YA, Bowyer RK, Leach H, et al. (IBS Dietetic Guideline Review Group on behalf of Gastroenterology Specialist Group of the British Dietetic Association). British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). Journal of Human Nutrition and Dietetics. 2016;29(5):549-575. https://doi.org/10.1111/jhn.12385
O’Keeffe M, Jansen C, Martin L, et al. Long-term impact of the low-FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability, and healthcare utilization in irritable bowel syndrome. Neurogastroenterology and Motility. 2018;30(1):10.1111/nmo.13154. https://doi.org/10.1111/nmo.13154
Whelan K, Martin LD, Staudacher HM, Lomer MCE. The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice. Journal of Human Nutrition and Dietetics. 2018;31(2):239-255. https://doi.org/10.1111/jhn.12530
Fassio F, Facioni MS, Guagnini F. Lactose Maldigestion, Malabsorption, and Intolerance: A Comprehensive Review with a Focus on Current Management and Future Perspectives. Nutrients. 2018;10(11):1599. https://doi.org/10.3390/nu10111599
Bahrami A, Gonoodi K, Khayyatzadeh SS, et al. The association of trace elements with premenstrual syndrome, dysmenorrhea and irritable bowel syndrome in adolescents. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2019;233:114-119. https://doi.org/10.1016/j.ejogrb.2018.12.017
Torres MJ, Sabate JM, Bouchoucha M, et al. Food consumption and dietary intakes in 36,448 adults and their association with irritable bowel syndrome: Nutrinet-Santé study. Therapeutic Advances in Gastroenterology. 2018;11: 1756283X17746625. https://doi.org/10.1177/1756283X17746625
Roth B, Larsson E, Ohlsson B. Poor intake of vitamins and minerals is associated with symptoms among patients with irritable bowel syndrome. Journal of Gastroenterology and Hepatology. 2022;37(7):1253-1262. https://doi.org/10.1111/jgh.15830
Barbalho SM, Goulart RA, Araújo AC, et al. Irritable bowel syndrome: a review of the general aspects and the potential role of vitamin D. Expert Review of Gastroenterology and Hepatology. 2019;13(4):345-359. https://doi.org/10.1080/17474124.2019.1570137
Philippou E, Nikiphorou E. Are we really what we eat? Nutrition and its role in the onset of rheumatoid arthritis. Autoimmunity Reviews. 2018;17(11):1074-1077. https://doi.org/10.1016/j.autrev.2018.05.009
Willebrand R, Kleinewietfeld M. The role of salt for immune cell function and disease. Immunology. 2018;154(3):346-353. https://doi.org/10.1111/imm.12915
Marion-Letellier R, Amamou A, Savoye G, Ghosh S. Inflammatory Bowel Diseases and Food Additives: To Add Fuel on the Flames! Nutrients. 2019; 11(5):1111. https://doi.org/10.3390/nu11051111
Wang C, Huang Z, Yu K, et al. High-Salt Diet Has a Certain Impact on Protein Digestion and Gut Microbiota: A Sequencing and Proteome Combined Study. Frontiers in Microbiology. 2017;8:1838. https://doi.org/10.3389/fmicb.2017.01838
Chen L, He FJ, Dong Y, et al. Modest Sodium Reduction Increases Circulating Short-Chain Fatty Acids in Untreated Hypertensives: A Randomized, Double-Blind, Placebo-Controlled Trial. Hypertension. 2020;76(1):73-79. https://doi.org/10.1161/HYPERTENSIONAHA.120.14800
Koloski NA, Jones M, Kalantar J, et al. The brain-gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut. 2012;61(9):1284-1290. https://doi.org/10.1136/gutjnl-2011-300474